Regeneron-Pharmaceuticals

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-02
Total Holdings
6
Total Value
1234240208
Accession Number
0001104659-25-044118
Form Type
13F-HR
Manager Name
Regeneron-Pharmaceuticals
Data Enrichment
100% identified
6 identified0 unidentified

Holdings

6 positions • $1.2B total value
Manager:
Search and click to pin securities to the top
ALNYLAM PHARMACEUTICALS, INC.
Shares:4.4M
Value:$1.2B
% of Portfolio:97.2% ($1.2B/$1.2B)
Intellia Therapeutics, Inc.
Shares:3.7M
Value:$26.3M
% of Portfolio:2.1% ($26.3M/$1.2B)
2seventy bio, Inc.
Shares:1.3M
Value:$6.2M
% of Portfolio:0.5% ($6.2M/$1.2B)
Adverum Biotechnologies, Inc.
Shares:180.9K
Value:$790.6K
% of Portfolio:0.1% ($790.6K/$1.2B)
Adicet Bio, Inc.
Shares:968.2K
Value:$731.0K
% of Portfolio:0.1% ($731.0K/$1.2B)
bluebird bio, Inc.
Shares:21.0K
Value:$102.5K
% of Portfolio:0.0% ($102.5K/$1.2B)